Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Dulaglutide reduces cardiovascular disease in Type-2 diabetic people

biospectrumasiaJune 10, 2019

Tag: Dulaglutide , Type-2 diabetic , Cardiovascular disease

PharmaSources Customer Service